If you have room in your portfolio for a blue chip ASX 200 share or two, then take a look at the top blue chips listed below.
Here's why these ASX 200 shares are highly rated:
CSL Limited (ASX: CSL)
The first ASX 200 share to consider is CSL. It is one of the world's leading biotechnology companies, comprising the CSL Behring, CSL Vifor, and Seqirus businesses.
As well as having a portfolio of a world-class, life-saving therapies, CSL invests 10% to 11% of its sales back into research and development (R&D) activities every year.
This means the company has a large number of potentially lucrative therapies under development to support its future growth. This includes its CSL112 therapy, which aims to reduce secondary heart attacks.
Morgans is positive on CSL and currently has an add rating and $337.92 price target on its shares.
Goodman Group (ASX: GMG)
Another blue chip ASX 200 share to look at is Goodman Group.
It is an industrial property company with a world-class property portfolio comprising warehouses, large-scale logistics facilities, and business and office parks. These properties are in demand and count some of the biggest companies in the world as tenants. This includes the likes of Amazon and DHL.
But like CSL, management isn't settling for that. The company has a material development pipeline that looks set to drive further solid growth in the coming years. At the last count, it has work in progress totalling $13.9 billion across 85 projects. This compares to its current assets under management of $79.5 billion.
Citi is very positive on the company's outlook and has a buy rating and a $24.00 price target on the company's shares.
